ALPHACENTRIC ADVISORS LLC Viracta Therapeutics, Inc. Transaction History

ALPHACENTRIC ADVISORS LLC portfolio value:

$0
portfolio value

ALPHACENTRIC ADVISORS LLC quarter portfolio value change:

+10.62%
quarter

Viracta Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -90K shares -329K $4.27 0
Q4 2021 share Decrease -2.60% -2.40K shares -412K $3.86 90K
Q3 2021 share 0.00% 0 shares -307K $8.02 92.40K
Q2 2021 share 0.00% 0 shares 193K $11.34 92.40K
Q1 2021 share Increase 0.00% 92.40K shares 855K $9.25 92.40K